Published: September 2019 (Web posted: August 2019)
Read Executive Summary Read Full-Text Guideline This guideline discusses indications for both conventionally fractionated radiation therapy and SBRT for pancreatic cancer in the adjuvant, neoadjuvant and definitive settings. It also provides recommendations on doses, target volumes, and sequencing with systemic therapies. Finally, considerations for simulation and treatment planning, technique and use of prophylactic medications to mitigate toxicity were assessed.
Developed in collaboration with:
Endorsed/supported by:
Resources: Guideline Slide Set Patient Materials - Questions by process stage, Treatment process diagram
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.